Conference Details - Overview
CME Accreditation and Credit Designation
Physicians:
Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource designates this educational activity for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Physician Assistants:
AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.
Third Symposium on Upper Gastrointestinal Malignancies
The Sofitel Philadelphia
Philadelphia, PA
Sep 6, 2008
Conference Overview
Conference Description & Purpose
The Third Symposium on Upper Gastrointestinal Malignancies is designed to update practicing medical, radiation, and surgical oncologists; gastroenterologists; nurses; and other clinicians on the broad advances made in the prevention, early diagnosis, and therapy of upper gastrointestinal malignancies in recent years. This symposium has been designed as an educational and scientific meeting that will provide cutting-edge updates on the biology, diagnosis, and multidisciplinary management of these diseases. Controversies and changes in treatment paradigms for these diseases will be reviewed. Investigational agents and targeted therapies will be discussed, including the context for their potential application in the treatment of upper gastrointestinal malignancies. This interactive symposium will include didactic sessions and case-based discussions with leading faculty that will address the clinical and surgical management of hepatocellular carcinoma, pancreatic cancer, and gastric and esophageal cancers. This symposium will promote education and collaborative investigation to advance the treatment standards for upper gastrointestinal malignancies within community practice.
Target Audience
This educational program is directed toward medical, surgical, and radiation oncologists; gastroenterologists; internal medicine and primary care physicians; and fellows interested in hepatocellular, pancreatic, gastric, and esophageal cancers. Nurses, physician assistants, and other individuals interested in the treatment of upper gastrointestinal malignancies are also invited to attend.
Learning Objectives
- Summarize clinical trial data on the surgical and clinical management of hepatocellular carcinoma in the adjuvant and advanced settings
- Evaluate the impact of targeted therapies on the treatment of hepatocellular carcinoma
- Discuss current concepts in the biology and pathology of pancreatic cancer
- Interpret current clinical data on surgical and chemotherapeutic treatment strategies for pancreatic cancer
- Debate the potential clinical benefit from and impact of antiangiogenic and EGFR-targeted agents on the efficacy of conventional chemotherapy in patients with pancreatic cancer
- Assess treatment choices for neuroendocrine cancers
- Compare chemotherapeutic approaches to and surgical strategies in the treatment of gastric and esophageal cancer in the adjuvant and neoadjuvant settings
- Discuss molecular targets for novel agents in the treatment of gastroesophageal cancers and the role of those targets in the disease process
Educational Grants
An educational grant for this activity was provided by:
- Bayer Healthcare Pharmaceuticals/Onyx Pharmaceuticals, Inc.
- Bristol-Myers Squibb/
ImClone Systems - Genentech BioOncology/
OSI Oncology - sanofi-aventis U.S.